On Oct. 8, 2020, the National Institutes of Health (NIH) awarded a Research Project Cooperative Agreement grant to Yale Cancer Center (YCC). The 2-year, $1.4 million U01 award will fund immuno-serological assays for monitoring COVID-19 in patients with hematologic malignancies. The NIH Cooperative Agreement grants support a discrete, specified, circumscribed research project to be performed by investigators in an area representing specific interests and competencies.